Therapeutic prospects of ceRNAs in COVID-19

Area of Science:

• Molecular Biology
• Virology
• Genetics

Background:

• COVID-19, caused by SARS-CoV-2, requires novel therapeutic strategies beyond current treatments.
• Long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs) are emerging as key regulators in viral infections.
• The competing endogenous RNA (ceRNA) network, involving lncRNA-miRNA-mRNA and circRNA-miRNA-mRNA interactions, plays a crucial role in disease pathogenesis.

Purpose of the Study:

• To review the impact of COVID-19 across multiple human body systems.
• To identify potential therapeutic targets among lncRNAs, miRNAs, and circRNAs in COVID-19 patients.
• To summarize current research on ceRNA networks in SARS-CoV-2 infection and predict novel therapeutic targets.

Main Methods:

• Comprehensive literature review of COVID-19 research.
• Analysis of lncRNAs, miRNAs, and circRNAs involvement in various body systems affected by SARS-CoV-2.
• Investigation of ceRNA networks (lncRNA-miRNA-mRNA and circRNA-miRNA-mRNA) in COVID-19.
• Prediction of therapeutic targets, including specific lncRNAs (MALAT1, NEAT1, TUG1, GAS5) and the PTEN gene.

Main Results:

• COVID-19 affects multiple organ systems, including respiratory, immune, digestive, circulatory, urinary, reproductive, and nervous systems.
• lncRNAs, miRNAs, and circRNAs are implicated in the pathogenesis of COVID-19.
• The ceRNA network, particularly involving MALAT1, TUG1, and the PTEN gene, presents promising therapeutic avenues for COVID-19 treatment.

Conclusions:

• Noncoding RNAs offer novel therapeutic targets for COVID-19.
• Understanding ceRNA networks provides insights into SARS-CoV-2 mechanisms.
• Targeting specific lncRNAs and their interactions within ceRNA networks, like those involving PTEN, could lead to effective COVID-19 therapies.